Serum cytokine levels in patients with Alzheimer's disease - PubMed (original) (raw)

Serum cytokine levels in patients with Alzheimer's disease

C C Chao et al. Clin Diagn Lab Immunol. 1994 Jul.

Abstract

Alzheimer's disease (AD) has been proposed to be an inflammatory disorder. In a recent study, markedly elevated levels of the anti-inflammatory cytokine transforming growth factor beta (TGF-beta) in the serum and cerebrospinal fluid of patients with advanced AD suggested a potential predictive value of this cytokine in patients with AD. In the present prospective study, we tested the hypothesis that the levels of TGF-beta in serum would be increased in patients with AD and could thereby serve as a diagnostic marker. We found that serum TGF-beta levels but not proinflammatory cytokine levels were significantly (P < 0.05) elevated in patients with AD (n = 22) in comparison with the levels in their healthy spousal controls. Also, serum TGF-beta levels were positively correlated (r = 0.45; P < 0.05) with disease severity. Nevertheless, the elevation in serum TGF-beta levels in patients with Ad was modest, and considerable overlap with the control values suggests that the diagnostic usefulness of this cytokine for AD is limited.

PubMed Disclaimer

Similar articles

• Transforming growth factor beta in Alzheimer's disease.
  Chao CC, Hu S, Frey WH 2nd, Ala TA, Tourtellotte WW, Peterson PK. Chao CC, et al. Clin Diagn Lab Immunol. 1994 Jan;1(1):109-10. doi: 10.1128/cdli.1.1.109-110.1994. Clin Diagn Lab Immunol. 1994. PMID: 7496909 Free PMC article.
• Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.
  Juraskova B, Andrys C, Holmerova I, Solichova D, Hrnciarikova D, Vankova H, Vasatko T, Krejsek J. Juraskova B, et al. J Nutr Health Aging. 2010 Nov;14(9):758-61. doi: 10.1007/s12603-010-0325-1. J Nutr Health Aging. 2010. PMID: 21085906
• Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia.
  Malaguarnera L, Motta M, Di Rosa M, Anzaldi M, Malaguarnera M. Malaguarnera L, et al. Neuropathology. 2006 Aug;26(4):307-12. doi: 10.1111/j.1440-1789.2006.00701.x. Neuropathology. 2006. PMID: 16961066
• Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease.
  De Servi B, La Porta CA, Bontempelli M, Comolli R. De Servi B, et al. Exp Gerontol. 2002 Jun;37(6):813-21. doi: 10.1016/s0531-5565(02)00018-9. Exp Gerontol. 2002. PMID: 12175481
• Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice.
  Masliah E, Ho G, Wyss-Coray T. Masliah E, et al. Neurochem Int. 2001 Nov-Dec;39(5-6):393-400. doi: 10.1016/s0197-0186(01)00046-8. Neurochem Int. 2001. PMID: 11578774 Review.

Cited by

• Excessive Production of Transforming Growth Factor β1 Causes Mural Cell Depletion From Cerebral Small Vessels.
  Kato T, Sekine Y, Nozaki H, Uemura M, Ando S, Hirokawa S, Onodera O. Kato T, et al. Front Aging Neurosci. 2020 Jun 3;12:151. doi: 10.3389/fnagi.2020.00151. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32581764 Free PMC article.
• Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.
  Docagne F, Gabriel C, Lebeurrier N, Lesné S, Hommet Y, Plawinski L, Mackenzie ET, Vivien D. Docagne F, et al. Biochem J. 2004 Oct 15;383(Pt 2):393-9. doi: 10.1042/BJ20040682. Biochem J. 2004. PMID: 15242331 Free PMC article.
• The role of the immune system in clearance of Abeta from the brain.
  Boche D, Nicoll JA. Boche D, et al. Brain Pathol. 2008 Apr;18(2):267-78. doi: 10.1111/j.1750-3639.2008.00134.x. Brain Pathol. 2008. PMID: 18363937 Free PMC article. Review.
• TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats.
  Shen WX, Chen JH, Lu JH, Peng YP, Qiu YH. Shen WX, et al. Int J Mol Sci. 2014 Dec 1;15(12):22092-108. doi: 10.3390/ijms151222092. Int J Mol Sci. 2014. PMID: 25470026 Free PMC article.
• TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.
  Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, Drago F, Sortino MA, Nicoletti F, Copani A. Caraci F, et al. CNS Neurosci Ther. 2011 Aug;17(4):237-49. doi: 10.1111/j.1755-5949.2009.00115.x. Epub 2009 Nov 19. CNS Neurosci Ther. 2011. PMID: 19925479 Free PMC article. Review.

References

1. 1. Am J Psychiatry. 1982 Sep;139(9):1136-9 - PubMed
2. 1. Clin Diagn Lab Immunol. 1994 Jan;1(1):109-10 - PubMed
3. 1. J Biol Chem. 1987 Oct 15;262(29):14090-9 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5 - PubMed
5. 1. Can J Neurol Sci. 1989 Nov;16(4 Suppl):535-42 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information